Investigations have demonstrated that activation of the STING signaling pathway causes indolamine 2,3-dioxygenase (IDO)-dependent effector T cell inhibition, promotes regulatory T cells (Tregs) activity, and induces immune tolerance, leading to tumor growth [33]. The gene discussed is STING1; the disease is neoplasm.